Autophagy Inhibition Potentiates Ruxolitinib-Induced Apoptosis in JAK2V617F Cells

被引：1
|
作者：
Machado-Neto, Joao Agostinho [1 ,2 ]
Coelho-Silva, Juan Luiz [1 ]
de Souza Santos, Fabio Pires [3 ]
Scheucher, Priscila Santos [1 ]
Campregher, Paulo Vidal [3 ]
Hamerschlak, Nelson [3 ]
Rego, Eduardo Magalhaes [1 ,4 ]
Traina, Fabiola [1 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil
[3] Albert Einstein Hosp, Einsteins Teaching & Res Inst, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1788
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of selective JAK inhibition in models of leukemia, lymphoma, myeloma, and JAK2V617F dependent malignancy
    Fridman, J. S.
    Caulder, E.
    Liu, P.
    Li, J.
    Scherle, P. A.
    Rodgers, J.
    Redman, J.
    Hollis, G.
    Newton, R. C.
    Vaddi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] JAK2V617F-Mutant Vascular Niche Promotes JAK2V617F Clonal Expansion in Myeloproliferative Neoplasms
    Zhan, Huichun
    Lin, Chi Hua Sarah
    Segal, Yarden
    Kaushansky, Kenneth
    BLOOD, 2016, 128 (22)
  • [43] JAK2V617F-mutant vascular niche contributes to JAK2V617F clonal expansion in myeloproliferative neoplasms
    Lin, Chi Hua Sarah
    Kaushansky, Kenneth
    Zhan, Huichun
    BLOOD CELLS MOLECULES AND DISEASES, 2016, 62 : 42 - 48
  • [44] Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic
    Maslah, Nabih
    Dagher, Tracy
    Edmond, Valerie
    Cassinat, Bruno
    Lallemand-Breitenbach, Valerie
    Verger, Emmanuelle
    Plo, Isabelle
    Kiladjian, Jean-Jacques
    Villeval, Jean-Luc
    de The, Hugues
    BLOOD, 2018, 132
  • [45] Application of mutant JAK2V617F for in vitro generation of red blood cells
    Lee, Sun Ah
    Kim, Ji Yeon
    Choi, Yongwook
    Kim, Yonggoo
    Kim, Hyun Ok
    TRANSFUSION, 2016, 56 (04) : 837 - 843
  • [46] JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles
    Hekimoglu, Hilal
    Toprak, Selin Fulya
    Sozer, Selcuk
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (01) : 13 - 21
  • [47] Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha.
    Lane, Steven W.
    Mullally, Ann
    ONCOTARGET, 2013, 4 (04) : 500 - 501
  • [48] The JAK2V617F mutation in normal individuals takes place in differentiating cells
    Krichevsky, Svetlana
    Prus, Eugenia
    Perlman, Riki
    Fibach, Eitan
    Ben-Yehuda, Dina
    BLOOD CELLS MOLECULES AND DISEASES, 2017, 63 : 45 - 51
  • [49] Givinostat and hydroxyurea synergize in vitro to induce apoptosis of cells from JAK2V617F myeloproliferative neoplasm patients
    Calzada, Ariel Amaru
    Pedrini, Olga
    Finazzi, Guido
    Leoni, Flavio
    Mascagni, Paolo
    Introna, Martino
    Rambaldi, Alessandro
    Golay, Josee
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (03) : 253 - 260
  • [50] Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
    Yonal-Hindilerden, Ipek
    Daglar-Aday, Aynur
    Akadam-Teker, Basak
    Yilmaz, Ceylan
    Nalcaci, Meliha
    Yavuz, Akif Selim
    Sargin, Deniz
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 157 - 175
12345